Cargando…
Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)—A Condition Associated with Heightened Sympathetic Activation
Metabolic dysfunction-associated fatty liver disease (MAFLD) is the most common liver disease affecting a quarter of the global population and is often associated with adverse health outcomes. The increasing prevalence of MAFLD occurs in parallel to that of metabolic syndrome (MetS), which in fact p...
Autores principales: | Carnagarin, Revathy, Tan, Kearney, Adams, Leon, Matthews, Vance B., Kiuchi, Marcio G., Marisol Lugo Gavidia, Leslie, Lambert, Gavin W., Lambert, Elisabeth A., Herat, Lakshini Y., Schlaich, Markus P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073135/ https://www.ncbi.nlm.nih.gov/pubmed/33921881 http://dx.doi.org/10.3390/ijms22084241 |
Ejemplares similares
-
Focusing on Sodium Glucose Cotransporter-2 and the Sympathetic Nervous System: Potential Impact in Diabetic Retinopathy
por: Herat, Lakshini Y., et al.
Publicado: (2018) -
Sympathetic Activation in Hypertensive Chronic Kidney Disease – A Stimulus for Cardiac Arrhythmias and Sudden Cardiac Death?
por: Kiuchi, Márcio Galindo, et al.
Publicado: (2020) -
Machine learning powered tools for automated analysis of muscle sympathetic nerve activity recordings
por: Nolde, Janis M., et al.
Publicado: (2021) -
Supine blood pressure—A clinically relevant determinant of vascular target organ damage in hypertensive patients
por: Nolde, Janis M., et al.
Publicado: (2020) -
New Approaches in the Management of Sudden Cardiac Death in Patients with Heart Failure—Targeting the Sympathetic Nervous System
por: Kiuchi, Márcio Galindo, et al.
Publicado: (2019)